Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Budi Starch Sweetener Tbk (BUDI) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance

Budi Starch Sweetener TbkTrade
Hetzer Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Budi Starch Sweetener Tbk vs Hetzer Medical Indonesia Tbk. — how do they compare? Budi Starch Sweetener Tbk trades at Rp222 (market cap 989.78B, 69.7K 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp72 (market cap 114.06B, 23.06M 24h volume). The key difference: Budi Starch Sweetener Tbk is far larger — about 8.7× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (23.06M versus 69.7K). Which is the better fit depends on your goals.

BUDIMEDS
Market Cap
989.78B114.06B
Volume
69.7K23.06M
Lot
697230.55K
Turnover
15.33M1.68B
Average Price
219.8972.75
Value
15.33M1.68B
Indicative Equilibrium Price
22272
Indicative Equilibrium Volume
21.56K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BUDI
View details
MEDS
View details

About Budi Starch Sweetener Tbk

PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.

Read more on BUDI

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS